Tarone, Lidia
Barutello, Giuseppina
Iussich, Selina
Giacobino, Davide
Quaglino, Elena
Buracco, Paolo
Cavallo, Federica http://orcid.org/0000-0003-4571-1060
Riccardo, Federica
Funding for this research was provided by:
Fondazione Ricerca Molinette Onlus (8893/5)
University of Turin (ex60% 2018)
Italian Ministry of Health (RF-2013-02359216)
Article History
Received: 31 January 2019
Accepted: 11 June 2019
First Online: 20 June 2019
Compliance with ethical standards
:
: The authors declare that no potential conflicts of interest exist.
: All the in vivo experiments were approved by the Italian Ministry of Health, authorization numbers 0006939-P-18/03/2015 (164/2015-PR) and 0004230-20/02/2018-DGSAF-MDS-P.
: Mice used for the vaccination experiments reported in this paper were purchased from Charles River Laboratories or bred at the Molecular Biotechnology Center, University of Turin, where all mice were maintained and treated in accordance with University Ethical Committee and European Union guidelines under Directive 2010/63. The canine patients that were enrolled in veterinary trials were client-owned dogs, whose institutes of reference were the Veterinary Teaching Hospital of the University of Turin and the Veterinary clinics of South Rome, Italy. Dogs were treated according to the Good Clinical Practice guidelines for animal clinical studies, and rules imposed by the Ethical Committee of the University of Turin (Italy).